Clozaril and Mirabegron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clozaril (clozapine) and Mirabegron (mirabegron). Common drug interactions include ideas of reference among females and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Clozaril and Mirabegron. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Clozaril?

Clozaril has active ingredients of clozapine. It is often used in schizophrenia. eHealthMe is studying from 65,127 Clozaril users. Check the latest studies of Clozaril.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.



On Jul, 09, 2026

47 people who take Clozaril and Mirabegron together, and have interactions are studied.

Clozaril and Mirabegron drug interactions.

What are the common drug interactions of Clozaril and Mirabegron, by gender? *:

female:

  1. Ideas of reference
  2. Leukopenia (less number of white blood cells in blood)
  3. Mood swings (an extreme or rapid change in mood)
  4. Mucosal inflammation (infection of mucous membrane)
  5. Nausea (feeling of having an urge to vomit)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  8. Non-small cell lung cancer (type of epithelial lung cancer)
  9. Overdose
  10. Pain

male:

  1. Urinary tract infection
  2. Constipation
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Body temperature increased
  5. Cardiac disorder
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Device occlusion
  8. General physical health deterioration (weak health status)
  9. Infection
  10. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)

What are the common drug interactions of Clozaril and Mirabegron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Bacterial infection
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Influenza
  5. Pneumonia
  6. Septic shock (shock due to blood infection)
  7. Vocal cord paralysis
  8. Anxiety

20-29:

n/a

30-39:

n/a

40-49:

  1. Constipation
  2. General physical health deterioration (weak health status)
  3. Intestinal obstruction

50-59:

  1. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  2. Volvulus (obstruction caused by twisting of the stomach or intestine)
  3. Fall
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Pneumonia influenzal (the flu with pneumonia)
  6. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  7. Urinary tract infection
  8. Hospitalisation
  9. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Constipation
  2. Intentional self-injury
  3. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  4. Breast cancer
  5. Chest pain
  6. Cyclothymic disorder (mood disorder)
  7. Delusion (a false belief or opinion)
  8. Depressed mood
  9. Emotional distress
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 22 people, 46.81%
  2. Constipation: 21 people, 44.68%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 40.43%
  4. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 19 people, 40.43%
  5. High Blood Pressure: 19 people, 40.43%
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 19 people, 40.43%
  7. Dry Eyes (lack of adequate tears): 19 people, 40.43%
  8. Diabetes: 19 people, 40.43%
  9. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 19 people, 40.43%
  10. Asthma: 18 people, 38.30%

* Approximation only. Some reports may have incomplete information.

Do you take Clozaril and Mirabegron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clozaril and Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clozaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clozaril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirabegron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clozapine and mirabegron (the active ingredients of Clozaril and Mirabegron, respectively), and Clozaril and Mirabegron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: